| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $10.7M | +48.4% |
| Cost of Revenue | $3.6M | +26.2% |
| Gross Profit | $7.0M | +63.2% |
| R&D Expense | $17.0M | +17.6% |
| SG&A Expense | $23.1M | +24.8% |
| Operating Income | -$33.1M | -15.4% |
| Pre-tax Income | -$27.8M | +2.2% |
| Income Tax | -$2K | +98.4% |
| Net Income | -$27.8M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $54.9M | +109.5% |
| Accounts Receivable | $7.0M | -3.3% |
| Inventory | $5.8M | -17.0% |
| Current Assets | $69.1M | +64.8% |
| Total Assets | $70.2M | +59.8% |
| Current Liabilities | $6.6M | +3.1% |
| Long-term Debt | $4.7M | -34.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.5M | -3.7% |
| Financing Cash Flow | $54.7M | +3014.8% |
| +1.8% |
| EPS (Basic) | $1.12 | -16.4% |
| EPS (Diluted) | $1.12 | -16.4% |
| Total Liabilities |
| $9.8M |
| -22.9% |
| Stockholders' Equity | $60.4M | +93.5% |